{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:49:56Z","timestamp":1759063796845,"version":"3.40.5"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.antiviral.2017.01.025","type":"journal-article","created":{"date-parts":[[2017,2,5]],"date-time":"2017-02-05T20:47:37Z","timestamp":1486327657000},"page":"158-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Pre-and post-pandemic trends in antiviral use in hospitalized patients with laboratory-confirmed influenza: 2004\/05\u20132013\/14, Toronto, Canada"],"prefix":"10.1016","volume":"140","author":[{"given":"Brenda L.","family":"Coleman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazi","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7570-3577","authenticated-orcid":false,"given":"Karen","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan B.","family":"Gubbay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Mazzulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelly","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2053-6083","authenticated-orcid":false,"given":"Jeff","family":"Powis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Simor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison J.","family":"McGeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.01.025_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/2006\/165940","article-title":"The use of antiviral drugs for influenza: recommended guidelines for practitioners","volume":"17","author":"Allen","year":"2006","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"10.1016\/j.antiviral.2017.01.025_bib2","article-title":"The use of antiviral drugs for influenza: guidance for practitioners, 2010-11","author":"Aoki","year":"2010","journal-title":"Assoc. Med. Microbiol. Infect. Dis. Can."},{"key":"10.1016\/j.antiviral.2017.01.025_bib3","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1155\/2012\/879141","article-title":"The use of antiviral drugs for influenza: guidance for practitioners 2012\/2013","volume":"23","author":"Aoki","year":"2012","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"10.1016\/j.antiviral.2017.01.025_bib4","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1093\/infdis\/jir648","article-title":"Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009","volume":"204","author":"Doshi","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.01.025_bib5","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.ajem.2014.09.032","article-title":"ED compliance with influenza antiviral recommendations","volume":"32","author":"Dugas","year":"2014","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.antiviral.2017.01.025_bib6","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/cis442","article-title":"Reduced influenza antiviral treatment among children and adults hospitalized with laboratory-confirmed influenza infection in the year after the 2009 pandemic","volume":"55","author":"Garg","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.01.025_bib7","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1086\/598513","article-title":"Seasonal influenza in adults and children - diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America","volume":"48","author":"Harper","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.01.025_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1750-2659.2011.00303.x","article-title":"Impact of the 2009\/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment","volume":"6","author":"Hernandez","year":"2012","journal-title":"Influenza Other Respir. Viruses"},{"year":"2000","series-title":"Applied Logistic Regression","author":"Hosmer","key":"10.1016\/j.antiviral.2017.01.025_bib9"},{"key":"10.1016\/j.antiviral.2017.01.025_bib10","series-title":"AMMI Canada 2016 Annual Conference","article-title":"Viral respiratory tract infections in the intensive care unit: clinical definitions, findings and outcomes","author":"Kassim","year":"2016"},{"key":"10.1016\/j.antiviral.2017.01.025_bib11","doi-asserted-by":"crossref","first-page":"e1539","DOI":"10.1542\/peds.2013-2149","article-title":"Neuraminidase inhibitors for critically ill children with influenza","volume":"132","author":"Louie","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.antiviral.2017.01.025_bib12","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1086\/523584","article-title":"Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada","volume":"45","author":"McGeer","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.01.025_bib13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S2213-2600(14)70041-4","article-title":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data","volume":"2","author":"Muthuri","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.antiviral.2017.01.025_bib14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cmi.2014.11.020","article-title":"Neuraminidase inhibitors: who, when, where?","volume":"21","author":"Nguyen-Van-Tam","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"year":"2009","series-title":"Interim guidance for emergency use of oseltamivir (Tamiflu\u00ae) in children under one year of age in the context of 2009 (H1N1) pandemic, Ottawa, ON","author":"Public Health Agency of Canada","key":"10.1016\/j.antiviral.2017.01.025_bib15"},{"key":"10.1016\/j.antiviral.2017.01.025_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jcv.2012.02.010","article-title":"Influenza in the immediate post-pandemic era: a comparison with seasonal and pandemic influenza in hospitalized patients","volume":"54","author":"Rahamat-Langendoen","year":"2012","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2017.01.025_bib17","unstructured":"StataCorp, 2009. Stata\/SE for Windows, 11.2 ed. StatCorp LP, College Station, TX."},{"key":"10.1016\/j.antiviral.2017.01.025_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2047-2994-3-2","article-title":"Trends in antiviral therapy of adults hospitalized with influenza in Canada since the end of the 2009 pandemic","volume":"3","author":"Taylor","year":"2014","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"10.1016\/j.antiviral.2017.01.025_bib19","unstructured":"World Health Organization, 2009. Epidemiological summary of pandemic influenza A (H1N1) 2009 virus - Ontario, Canada, June 2009. Wkly. Epidemiol. Rec.. 84, 485\u2013492."},{"year":"2014","series-title":"Influenza (Seasonal), Geneva, Switzerland","author":"World Health Organization","key":"10.1016\/j.antiviral.2017.01.025_bib20"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421630612X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421630612X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T04:50:24Z","timestamp":1568782224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421630612X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":20,"alternative-id":["S016635421630612X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.01.025","relation":{},"ISSN":["0166-3542"],"issn-type":[{"type":"print","value":"0166-3542"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-and post-pandemic trends in antiviral use in hospitalized patients with laboratory-confirmed influenza: 2004\/05\u20132013\/14, Toronto, Canada","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}